Does oral terbutaline prevent asymptomatic nocturnal hypoglycaemia in children with insulin dependent diabetes mellitus in a clinical setting?

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN22414310

Enrollment

Registered

2003-09-12

Start date

2002-11-01

Completion date

Unknown

Last updated

2018-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Nutritional, Metabolic, Endocrine Insulin dependent diabetes mellitus

Interventions

Twenty-five diabetic children will be recruited from the population attending the diabetes clinic in Sheffield. They will be visited at home on three separate occasions by a diabetes research nurse. F

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Twenty-five diabetic children will be recruited from the population attending the diabetes clinic in Sheffield

Exclusion criteria

Exclusion criteria: Does not match inclusion criteria

Design outcomes

Primary

Measure	Time frame
The main outcome measures are: 1. Differences in the number of nights when hypoglycaemia occurs between placebo and terbutaline treatment 2. The effect on blood sugar assessed by comparing the children's home blood glucose measurements before/after the bedtime dose	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026